The study aims to determine the effectiveness of low-dose aspirin as an add-on treatment for bipolar disorder.
Conducted a randomised controlled trial comparing low-dose aspirin and placebo.
Included individuals diagnosed with bipolar disorder as participants.
Monitored treatment effects and participant responses to both interventions.
No significant difference in treatment outcomes between low-dose aspirin and placebo.
Low-dose aspirin did not provide additional benefits for bipolar disorder management.
Abstract
Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
问 AI
Like
Bookmark
Share
View Full Paper
问 AI
Like
Bookmark
Share
View Full Paper
No Effect of Low‐Dose Aspirin Versus Placebo as Add‐On Treatment in Bipolar Disorder—Results From a Randomised Controlled Trial (the A‐Bipolar RCT ) | Synapse